March 15, 2022

Deciphex at Digital Pathology & AI Conference 2022

Deciphex will be participating in the Digital Pathology & AI Conference 2022 happening virtually, from the 24-25th of March. This event is hosted by Curtis & Wyss and will focus on the latest trends and developments in the digital pathology field. The conference will consist of two days of presentations, virtual roundtable discussions and interactive Q&A panel sessions. 

We will be hosting a symposium presentation on Friday the 25th of March at 10:40 am GMT. Our Director of Commercial AI Services, Trevor McKee, will be presenting on the topic “Finding the Lesion Needle in the Normal Tissue Haystack: How AI and AI-As-A-Service, With Robust QC & Validation, Can Deliver Quantitative Insights to Help Guide Decision Making in Drug Safety Assessment”.

To find out more about our involvement in this event and how you can attend please fill out the form below.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.
return to news

Contact Details

Invent Buidling at DCU


DCU Alpha Building, Innovation Campus,
11 Old Finglas Rd, Glasnevin, Co. Dublin
D11 KXN4

Call: +353 1 582 7193


Twitter: @deciphex

USA Headquarters Building


Deciphex Inc.
1012 95th Street, Naperville,
Chicago, Illinois

Call: +1 708 573 0674


USA Headquarters Building


Exeter Science Park Centre,
6 Babbage Way, Exeter

Call: +44 1 29730 2245



Oxford Accessioning Centre (UK)
Diagnexia UK Limited,
John Eccles House
Robert Robinson Ave,

Email Us

The details you submit will be used so that we can contact you in relation to your query either by email or your preferred method of contact. Read our privacy policy here.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form
Copyright Deciphex 2021
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.